Fortrea Holdings Inc. (FTRE) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

Total Cash From Operating Activities Chart for Fortrea Holdings Inc.

Fortrea Holdings Inc. (FTRE) operating cash flow for FY2025 was USD 113.5M, a -56.8% change from FY2024. Fortrea Holdings Inc.'s operating cash flow grew from USD 200.9M in 2020 to USD 113.5M in 2025 (-43.5% over 5 years). Operating cash flow compound annual growth rate: 5-year CAGR of -10.8%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$2.25B
Implied Share Price
$23.63
Enterprise Value
$2.03B
Revenue (TTM)
$2.68B
EBITDA
$98.30M
Profit Margin
-3.18%
Trailing P/E
—
Forward P/E
6.12
Price/Book (MRQ)
1.48
Price/Sales (TTM)
0.84
EV/EBITDA
92.35
EV/Revenue
0.74
Dividend Yield
—
Book Value
$5.51
Free Cash Flow (FY2025)
$88.30M
Free Cash Flow Yield
3.93%

Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.